Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Daiichi Sankyo
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Apollomics Inc.
Rain Oncology Inc
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
MultiVir, Inc.
Eli Lilly and Company
Ipsen
Wake Forest University Health Sciences
Roswell Park Cancer Institute
National University Hospital, Singapore
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Adherex Technologies, Inc.